← Back to Search

Integrase Inhibitor

Delayed switch for Obesity (ADIPOSITY Trial)

N/A
Waitlist Available
Led By Jane O'Halloran, MB BA PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

ADIPOSITY Trial Summary

This trial will compare the effects of different HIV medication regimens on blood sugar, fat storage, and MRI scans.

Eligible Conditions
  • Obesity
  • HIV

ADIPOSITY Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Adipocyte gene expression correlated with adipose tissue development
Adipocyte size measured by osmium tetroxide fixation technique
Insulin Sensitivity measured by homeostatic model assessment for insulin resistance {HOMA_IR}
+1 more

ADIPOSITY Trial Design

2Treatment groups
Active Control
Group I: Delayed switchActive Control3 Interventions
Delayed switch
Group II: Immediate switchActive Control3 Interventions
Immediate switch

Find a Location

Who is running the clinical trial?

Janssen Scientific Affairs, LLCIndustry Sponsor
159 Previous Clinical Trials
580,510 Total Patients Enrolled
3 Trials studying Obesity
76 Patients Enrolled for Obesity
Washington University School of MedicineLead Sponsor
1,931 Previous Clinical Trials
2,299,701 Total Patients Enrolled
77 Trials studying Obesity
13,809 Patients Enrolled for Obesity
Jane O'Halloran, MB BA PhDPrincipal Investigator - Washington University School of Medicine in St. Louis
Washington University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism
Jane O'Halloran 2021. "Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04675255.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top